Registration
Introduction
Nexavar - A Novel Inhibitor of Signal Transduction
Design, Synthesis and Biological Activity of Therapeutics Targeting the PI3K Pathway
Coffee-break & poster session
Discovery of Sitagliptin and Other Novel DPP4 Inhibitors
Hit-to-lead studies on Aminopropoxy phenyloxazolines. Discovery of a novel class of potent H3R ligands for the treatment of cognitive dysfunction
Sandwich lunch & posters
Dual NK3/NK1 Receptor Antagonism: A Novel Approach for the Treatment of Psychotic Disorders
Isoindolinones as promising inhibitors of the MDM2-P53 protein-protein interaction
ETHR inhibitors as TB drug boosters: A new strategy to fight tuberculosis
Coffee-break & poster session
Discovery of R256918 a Gut-Selective MTP Inhibitor to Treat Obesity
Inhibitors of Thrombin Activatable Fibrinolysis Inhibitor (TAFIa)
Closing remarks